Asset Details
Do you wish to reserve the book?
A systematic review of the cognitive effects of the COMT inhibitor, tolcapone, in adult humans
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A systematic review of the cognitive effects of the COMT inhibitor, tolcapone, in adult humans
Do you wish to request the book?
A systematic review of the cognitive effects of the COMT inhibitor, tolcapone, in adult humans
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A systematic review of the cognitive effects of the COMT inhibitor, tolcapone, in adult humans
2024
Overview
The catechol-
-methyltransferase (COMT) inhibitor tolcapone constitutes a potentially useful probe of frontal cortical dopaminergic function. The aim of this systematic review was to examine what is known of effects of tolcapone on human cognition in randomized controlled studies.
The study protocol was preregistered on the Open Science Framework. A systematic review was conducted using PubMed to identify relevant randomized controlled trials examining the effects of tolcapone on human cognition. Identified articles were then screened against inclusion and exclusion criteria.
Of the 22 full-text papers identified, 13 randomized control trials were found to fit the pre-specified criteria. The most consistent finding was that tolcapone modulated working memory; however, the direction of effect appeared to be contingent on the COMT polymorphism (more consistent evidence of improvement in Val-Val participants). There were insufficient nature and number of studies for meta-analysis.
The cognitive improvements identified upon tolcapone administration, in some studies, are likely to be due to the level of dopamine in the prefrontal cortex being shifted closer to its optimum, per an inverted U model of prefrontal function. However, the results should be interpreted cautiously due to the small numbers of studies. Given the centrality of cortical dopamine to understanding human cognition, studies using tolcapone in larger samples and across a broader set of cognitive domains would be valuable. It would also be useful to explore the effects of different dosing regimens (different doses; and single versus repeated administration).
Publisher
Cambridge University Press
Subject
/ Benzophenones - pharmacology
/ Benzophenones - therapeutic use
/ Catechol O-Methyltransferase - genetics
/ Catechol O-Methyltransferase Inhibitors - pharmacology
/ Catechol O-Methyltransferase Inhibitors - therapeutic use
/ Dementia
/ Dopamine
/ Enzymes
/ Humans
/ Memory
/ Memory, Short-Term - drug effects
/ Post traumatic stress disorder
/ Randomized Controlled Trials as Topic
/ Review
